Philipp Ackermann

Philipp Ackermann

Auto-generated profile, based on publicly available information

Philipp Ackermann

Process Systems Engineering (AVT.SVT), RWTH Aachen University, 52074 Aachen, Germany

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2016 in Ophthalmologica
Verified
Journal Article
Closed access
AKAndré Klamann
André Klamann
KBKatharina Böttcher
Katharina Böttcher
PAPhilipp Ackermann
Philipp Ackermann
GGGerd Geerling
Gerd Geerling
MSMarc Schargus
Marc Schargus
RGRainer Guthoff
Rainer Guthoff
Introduction: Macular edema after cataract surgery (Irvine-Gass syndrome) or pars plana vitrectomy is a postoperative complication which can lead to permanent visual loss. Increased inflammatory substances, such as prostaglandins and cytokines, are discussed to be causative. Currently, there are no evidence-based guidelines for the treatment of postoperative macular edema. Intravitreal dexamethasone (DEX) could be effective by its anti-inflammatory effect. We examined the functional and morphological results of treatment with 0.7 mg intravitreal DEX implant (Ozurdex®). Methods: In an observational study, we analyzed visual acuity (logMAR), intraocular pressure (IOP), clinical findings, and the central macular thickness (CMT, optical coherence tomography [OCT] Spectralis®, Heidelberg Engineering, 30° macular scan, 19 scans) of 12 eyes before and 1 month after the last DEX implantation (off-label use, Ozurdex®, Allergan, Inc., Irvine, CA, USA) for macular edema after cataract surgery or vitrectomy. Re-implantation was performed when OCT showed new intraretinal fluid along with a decrease in the patient's visual acuity. The mean follow-up was 14.4 ± 10.6 months. Results: Twelve eyes of 12 patients (4 female, 8 male) with a mean age of 62.6 ± 11.9 years were treated with a mean of 2.5 ± 1.6 intravitreal DEX implant injections. Prior to injection, the visual acuity was 0.74 ± 0.34 logMAR and the CMT was 608 ± 129 µm. One month after the last injection (after a mean of 437 ± 322 days), the CMT normalized (300 ± 90 µm, p < 0.01) in all cases with a visual acuity of 0.49 ± 0.43 logMAR (p < 0.01). After 8.1 ± 5.3 months, recurring macular edema could be completely reduced by re-injection in 66% (8 patients). Four patients had no recurrence. Postinjection, the mean IOP was 17.4 ± 6.8 mm Hg. Postinjection, 7 patients required topical antiglaucomatous therapy. Conclusions: Treatment with an intravitreal DEX implant is an effective therapy for postoperative macular edema. Each injection leads to a complete resorption of the edema with a significant increase in visual acuity.

8 October 2021 in ChemSusChem
Verified
Journal Article
Open access
PDF file
PAPhilipp Ackermann
Philipp Ackermann
KBKarsten E. Braun
Karsten E. Braun
PBPatrick Burkardt
Patrick Burkardt
SHSebastian Heger
Sebastian Heger
AKAndrea König
Andrea König
MDManuel Dahmen
Manuel Dahmen
Model‐based fuel design can tailor fuels to advanced engine concepts while minimizing environmental impact and production costs. A rationally designed ketone‐ester‐alcohol‐alkane (KEAA) blend for high efficiency spark‐ignition engines was assessed in a multi‐disciplinary manner, from production cost to ignition characteristics, engine performance, ecotoxicity, microbial storage stability, and carbon footprint. The comparison included RON 95 E10, ethanol, and two previously designed fuels. KEAA showed high indicated efficiencies in a single‐cylinder research engine. Ignition delay time measurements confirmed KEAA's high auto‐ignition resistance. KEAA exhibits a moderate toxicity and is not prone to microbial infestation. A well‐to‐wheel analysis showed the potential to lower the carbon footprint by 95 percent compared to RON 95 E10. The findings motivate further investigations on KEAA and demonstrate advancements in model‐based fuel design.

11 March 2024 in Sustainable Energy & Fuels
Verified
Journal Article
Open access
PDF file
SVSimon Voelker
Simon Voelker
PAPhilipp Ackermann
Philipp Ackermann
MGMarcel Granderath
Marcel Granderath
CKClemens Kortmann
Clemens Kortmann
JVJoern Viell
Joern Viell
NANiklas von der Assen
Niklas von der Assen
This work identifies key environmental objectives from life cycle assessment for integrated process and fuel design of spark-ignition engine fuels.

25 May 2026 in Sustainable Energy & Fuels
Verified
Journal Article
Open access
PDF file
MAMoreno Ascani
Moreno Ascani
LBLisa Burkart
Lisa Burkart
PAPhilipp Ackermann
Philipp Ackermann
TBTabea Becker
Tabea Becker
MPMarian Panofen
Marian Panofen
SHSonja Herres-Pawlis
Sonja Herres-Pawlis
We evaluate and establish a new integrated recycling route using bio-based polylactide and biomass as feedstocks for novel green fuel candidates.